Researchers found that 160 milligrams of daily aspirin significantly lowered cancer recurrence risk for colorectal patients with PIK3 pathway alterations.

A daily low dose of aspirin could sharply cut the risk of colorectal cancer returning after surgery, according to a large ...

Key Takeaways Daily aspirin can cut in half the risk that colon cancer will come backRisk of recurrence was 55% lower in ...

A study involving more than 1,000 cancer patients has found that a low dose of aspirin halves the risk of colorectal tumors ...